Mechanism and functional impact of cd40 ligand-induced von willebrand factor release from endothelial cells

Thrombosis and Haemostasis

Volumn 113, Issue 5, 2015, Pages 1095-1108

  Möller, Kerstin ^a   Adolph, Oliver ^a   Grünow, Jennifer ^a   Elrod, Julia ^a   Popa, Miruna ^a   Ghosh, Subhajit ^a   Schwarz, Manuel ^a   Schwale, Chrysovalandis ^a   Grässle, Sandra ^a   Huck, Volker ^a   Bruehl, Claus ^a   Wieland, Thomas ^a   Schneider, Stefan W ^a   Nobiling, Rainer ^a   Wagner, Andreas H ^a   Hecker, Markus ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

CD154; CD40; Endothelial cells; Monocyte macrophages; Platelets; Remodelling; Vascular; Von willebrand factor

Indexed keywords

CALCIUM; CD40 LIGAND; PADGEM PROTEIN; PHOSPHOLIPASE C GAMMA1; PROTEIN TYROSINE KINASE; VON WILLEBRAND FACTOR; PHOSPHOLIPASE C; RECOMBINANT PROTEIN; SELP PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CAROTID ARTERY; CELL CULTURE; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMAGING; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SHEAR STRESS; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR REMODELING; WEIBEL PALADE BODY; WESTERN BLOTTING; ANIMAL; ARTERY; CELL ADHESION; CEREBROVASCULAR ACCIDENT; CHEMISTRY; COMMON CAROTID ARTERY; CYTOLOGY; ELECTROPHYSIOLOGY; FLUORESCENCE MICROSCOPY; INFLAMMATION; ISCHEMIA; METABOLISM; MOUSE; PATHOLOGY; PERFUSION; SHEAR STRENGTH; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BLOOD PLATELETS; CALCIUM; CAROTID ARTERY, COMMON; CD40 LIGAND; CELL ADHESION; ELECTROPHYSIOLOGY; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; ISCHEMIA; MICE; MICROSCOPY, FLUORESCENCE; MONOCYTES; P-SELECTIN; PERFUSION; RECOMBINANT PROTEINS; SHEAR STRENGTH; SIGNAL TRANSDUCTION; STROKE; TYPE C PHOSPHOLIPASES; VON WILLEBRAND FACTOR; WEIBEL-PALADE BODIES;

EID: 84931281974     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH14-04-0336     Document Type: Article

References (46)

1. Weber C, Noels H. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 2011; 17: 1410–1422.
2. Simionescu M. Implications of early structural-functional changes in the endothelium for vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 266–274.
3. Bernardo A, Ball C, Nolasco L, et al. Platelets adhered to endothelial cell-bound ultra-large von Willebrand factor strings support leukocyte tethering and rolling under high shear stress. J Thromb Haemost 2005; 3: 562–570.
4. Dole VS, Bergmeier W, Mitchell HA, et al. Activated platelets induce Weibel-Palade- body secretion and leukocyte rolling in vivo: role of P-selectin. Blood 2005; 106: 2334–2339.
5. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol 2009; 85: 195–204.
6. Petri B, Broermann A, Li H, et al. Von Willebrand factor promotes leukocyte extravasation. Blood 2010; 116: 4712–4719.
7. Hansson GK, Libby P, Schonbeck U, et al. Innate and adaptive immunity in the pathogenesis of atherosclerosis. Circ Res 2002; 91: 281–291.
8. Korff T, Aufgebauer K, Hecker M. Cyclic stretch controls the expression of CD40 in endothelial cells by changing their transforming growth factor-beta1 response. Circulation 2007; 116: 2288–2297.
9. Henn V, Steinbach S, Buchner K, et al. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 2001; 98: 1047–1054.
10. Wagner AH, Guldenzoph B, Lienenluke B, et al. CD154/CD40-mediated expression of CD154 in endothelial cells: consequences for endothelial cell-monocyte interaction. Arterioscler Thromb Vasc Biol 2004; 24: 715–720.
11. Morigi M, Zoja C, Figliuzzi M, et al. Fluid shear stress modulates surface expression of adhesion molecules by endothelial cells. Blood 1995; 85: 1696–1703.
12. Malek AM, Alper SL, Izumo S. Hemodynamic shear stress and its role in atherosclerosis. J Am Med Assoc 1999; 282: 2035–2042.
13. Heil M, Ziegelhoeffer T, Wagner S, et al. Collateral artery growth (arteriogenesis) after experimental arterial occlusion is impaired in mice lacking CC-chemokine receptor-2. Circ Res 2004; 94: 671–677.
14. Berriman JA, Li S, Hewlett LJ, et al. Structural organisation of Weibel-Palade bodies revealed by cryo-EM of vitrified endothelial cells. Proc Natl Acad Sci USA 2009; 106: 17407–1712.
15. Wagner DD, Frenette PS. The vessel wall and its interactions. Blood 2008; 111: 5271–5281.
16. Lenting PJ, Casari C, Christophe OD, et al. Von Willebrand factor: the old, the new and the unknown. J Thromb Haemost 2012; 10: 2428–2437.
17. Lienenluke B, Germann T, Kroczek RA, et al. CD154 stimulation of interleukin- 12 synthesis in human endothelial cells. Eur J Immunol 2000; 30: 2864–2870.
18. Berson RE, Purcell MR, Sharp MK. Computationally determined shear on cells grown in orbiting culture dishes. Adv Exp Med Biol 2008; 614: 189–198.
19. Wagner AH, Hildebrandt A, Baumgarten S, et al. Tyrosine nitration limits stretch-induced CD40 expression and disconnects CD40 signalling in human endothelial cells. Blood 2011; 118: 3734–3742.
20. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
21. De Ceunynck K, Rocha S, Feys HB, et al. Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis. J Biol Chem 2011; 286: 36361–36367.
22. Chen H, Fallah MA, Huck V, et al. Blood-clotting-inspired reversible polymercolloid composite assembly in flow. Nat Commun 2013; 4: 1333.
23. Cazenave JP, Ohlmann P, Cassel D, et al. Preparation of washed platelet suspensions from human and rodent blood. Methods Mol Biol 2004; 272: 13–28.
24. Xiong Y, Huo Y, Chen C, et al. Vascular endothelial growth factor (VEGF) receptor- 2 tyrosine 1175 signalling controls VEGF-induced von Willebrand factor release from endothelial cells via phospholipase C-gamma 1– and protein kinase A-dependent pathways. J Biol Chem 2009; 284: 23217–23224.
25. Kim YM, Lee YM, Kim HS, et al. TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 2002; 277: 6799–6805.
26. Tas PW, Stobetael C, Roewer N. The volatile anesthetic isoflurane inhibits the histamine-induced Ca2+ influx in primary human endothelial cells. Anesth Analg 2003; 97: 430–435.
27. Ying H, Li Z, Yang L, et al. Syk mediates BCR- and CD40-signalling integration during B cell activation. Immunobiology 2011; 216: 566–570.
28. Donners MM, Beckers L, Lievens D, et al. The CD40-TRAF6 axis is the key regulator of the CD40/CD40L system in neointima formation and arterial remodelling. Blood 2008; 111: 4596–4604.
29. Ding SF, Ni M, Liu XL, et al. A causal relationship between shear stress and atherosclerotic lesions in apolipoprotein E knockout mice assessed by ultrasound biomicroscopy. Am J Physiol Heart Circ Physiol 2010; 298: H2121–2129.
30. Borissoff JI, Spronk HM, ten Cate H. The hemostatic system as a modulator of atherosclerosis. N Engl J Med 2011; 364: 1746–1760.
31. Methia N, Andre P, Denis CV, et al. Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood 2001; 98: 1424–1428.
32. Jin SY, Tohyama J, Bauer RC, et al. Genetic ablation of Adamts13 gene dramatically accelerates the formation of early atherosclerosis in a murine model. Arterioscler Thromb Vasc Biol 2012; 32: 1817–1823.
33. Gandhi C, Khan MM, Lentz SR, et al. ADAMTS13 reduces vascular inflammation and the development of early atherosclerosis in mice. Blood 2012; 119: 2385–2391.
34. Lopez JA, Dong JF. Shear stress and the role of high molecular weight von Willebrand factor multimers in thrombus formation. Blood Coagul Fibrinolysis 2005; 16 (Suppl 1): S11–16.
35. De Ceunynck K, De Meyer SF, Vanhoorelbeke K. Unwinding the von Willebrand factor strings puzzle. Blood 2013; 121: 270–277.
36. Tsai HM, Lian EC. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585–1594.
37. Levy GG, Nichols WC, Lian EC, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature 2001; 413: 488–494.
38. Zhang X, Halvorsen K, Zhang CZ, et al. Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor. Science 2009; 324: 1330–1334.
39. Crawley JT, de Groot R, Xiang Y, et al. Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor. Blood 2011; 118: 3212–3221.
40. Chen J, Ling M, Fu X, et al. Simultaneous Exposure of Sites in von Willebrand Factor for Glycoprotein Ib Binding and ADAMTS13 Cleavage: Studies With Ristocetin. Arterioscler Thromb Vasc Biol 2012; 32: 2625–2630.
41. Kling SJ, Judd CA, Warner KB, et al. Regulation of ADAMTS13 expression in proliferating human umbilical vein endothelial cells. Pathophysiol Haemost Thromb 2008; 36: 233–240.
42. Yan JC, Wu ZG, Kong XT, et al. Effect of CD40--CD40 ligand interaction on diacylglycerol- protein kinase C and inositol trisphosphate-Ca(2+) signal transduction pathway in human umbilical vein endothelial cells. Clin Chim Acta 2003; 337: 133–140.
43. Liu F, Huang J, Sadler JE. Shiga toxin (Stx)1B and Stx2B induce von Willebrand factor secretion from human umbilical vein endothelial cells through different signalling pathways. Blood 2011; 118: 3392–3398.
44. Babich V, Meli A, Knipe L, et al. Selective release of molecules from Weibel-Palade bodies during a lingering kiss. Blood 2008; 111: 5282–5290.
45. Liu B, Lu S, Zheng S, et al. Two distinct phases of calcium signalling under flow. Cardiovasc Res 2011; 91: 124–133.
46. Cao WJ, Niiya M, Zheng XW, et al. Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells. J Thromb Haemost 2008; 6: 1233–1235.